Skip to main content
. 2016 Dec 20;13(1):71–87. doi: 10.1007/s13181-016-0595-z

Table 1.

Overview of case series, individual case report synthesis, and cumulative synthesis

Article Sample (n) Male n (%) Female n (%) Age (years) at diagnosis median (IQR) Cannabis use age (years) of onset median (IQR) Age (years) at symptom onset median (IQR) Duration of cannabis use (years) prior to symptom onset median (IQR) Cannabis use n (frequency of use) Cyclic vomiting n (%) Abdominal pain n (%) Relief with hot bathing % (n/total queried) Relief with abstinence or reduction % (n/total queried)
Simonetto* [12] 98 66(67) 32(33) Mean = 32.3 (±9.9) na Mean = 25.3 ±8.9 (n = 98) 32 (≤1), 42 (2–5), 11 (6–10), 13 (≥11) (n = 98) 58 (daily), 35 (weekly), 5 (<weekly) (n = 98) 98 (100) 84 (86) 91 (52/57) 100 (6/6)
Allen [6] 9 6(66) 3(33) 29 (21–37) (n = 9) 17 (15.5–18.5) (n = 9) 22 (15.8–28.3) (n = 9) 0 (≤1), 5 (2–5), 1 (6–10), 3 (≥11) (n = 9) 9 (>daily) (n = 9) 9 (100) na 88 (8/9) 100 (7/7)
Soriano-Co [12] 8 5(63) 3(37) 34 (31.9–36.2) (n = 8) 13 (11.3–14.8) (n = 8) 30.5 (32.4–32.4) (n = 8) 0 (≤1), 0 (2–5), 1 (6–10), 7 (≥11) (n = 8) 8 (>daily) (n = 8) 8 (100) 8 (100) 100 (8/8) 80 (4/5)
Wallace b [10] 31 24(78) 7(22) 34 (27.8–40.3) (n = 32) 16 (14–18) (n = 27) 24 (18.3–29.8) (n = 27) 2 (≤1), 9 (2–5), 3 (6–10), 12 (≥11) (n = 26) 28(>daily), 3 (quantity not specified) (n = 31) 31 (100) na 96 (29/30) 96 (24/25)
Sofka [13] 4 3(75) 1(25) 25.5 (22.3–28.6) (n = 4) 16 (14.5–17.5) (n = 4) 14 (11.5–16.5) (n = 4) 0 (≤1), 0 (2–5), 3 (6–10), 1 (≥11) (n = 4) 4 (>daily) (n = −4) 4 (100) 4 (100) 100 (4/4) 100 (1/1)
Patterson [10] 4 4(100) 0(0) 29 (24.6–33.4) (n = 4) 15.5 (14.9–16.1) (n = 4) 27.5 (18.5–36.5) (n = 4) 1 (≤1), 1 (2–5), 0 (6–10), 2 (≥11) (n = 4) 1 (>daily) 3 (daily) (n = 4) 4 (100) 3 (75) 100 (4/4) 100 (4/4)
Nicolson [15] 4 2(50) 2(50) 23 (21.3–24.6) (n = 4) 16.5 (15.6–17.4) (n = 4) 20 (17.5–22.5) (n = 4) 1 (≤1), 1 (2–5), 2 (6–10), 0 (≥11) (n = 4) 1 (>daily) 3 (daily) (n = 4) 4 (100) 3 (75) 100 (4/4) 100 (2/2)
Masri [14] 4 4(100) 0(0) 25 (22.6–27.4) (n = 4) 16 (14–18) (n = 2) 22 (19.4–24.6) (n = 4) 0 (≤1), 0 (2–5), 1 (6–10), 0 (≥11) (n = 1) 1 (>daily), 1 (daily), 0 (weekly), 2 (quantity not specified) (n = 4) 4 (100) 4 (100) 100 (4/4) 100 (1/1)
Individual case report synthesis 80 64(80) 16(20) 28.5 (22.6–34.4) (n = 78) 16 (12–18) (n = 53) 24 (19.5–28.5) (n = 68) 11 (≤1), 16 (2–5), 11 (6–10), 13 (≥11) (n = 51) 26 (>daily), 36 (daily), 6 (weekly), 12 (quantity not specified) (n = 80) 80 (100) 66 (82) 91 (73/80) 97 (37/38)
Cumulative synthesis 211 154 (72.9) 57 (27.1) 28 (12) (n = 111) 16 (4) (n = 84) 24 (10) (n = 101) 45 (≤1) 65 (2–5) 30 (6–10) 39 (≥11) (n = 179) 50 (>daily), 101 (daily), 41 (weekly), 5 (< weekly), 14 (quantity not specified) (n = 211) 100 (211) 172 (85.1) (n = 202) 92.3 (157/170) 96.8 (62/64)

aRaw data not available, statistics represented as reported by study authors

bNot included in cumulative synthesis as raw data not available

HHS Vulnerability Disclosure